BeyondSpring Inc.
Clinical-stage biopharma company developing immuno-oncology cancer therapies.
BYSI | US
Overview
Corporate Details
- ISIN(s):
- KYG108301006
- LEI:
- Country:
- United States of America
- Address:
- 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, 7932 FLORHAM PARK
- Sector:
- Manufacturing
Description
BeyondSpring Inc. is a clinical-stage biopharmaceutical company that develops innovative immuno-oncology cancer therapies. The company's primary focus is on addressing unmet medical needs and improving clinical outcomes for cancer patients. Its pipeline includes a lead asset, Plinabulin, which is a first-in-class small molecule agent. Additionally, the company operates a Targeted Protein Degradation (TPD) platform to advance other potential treatments. BeyondSpring is committed to developing novel cancer therapies to enhance the standard of care in oncology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BeyondSpring Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BeyondSpring Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BeyondSpring Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
